Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 448

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 448
---
 | ​       | ​ |       ​ | ​ | ​ |
| Assets:                                 | ​ | ​ | ​                   | ​ |         ​ | ​ | ​ | ​ | ​       | ​ |         ​ | ​ | ​ | ​ | ​       | ​ | ​ | ​ | ​ | ​ | ​       | ​ |       ​ | ​ | ​ |
| Cash equivalents held in Trust          | ​ | ​ | ​                   | ​ | 4,291,332 | ​ | ​ | ​ | ​       | ​ | 4,291,332 | ​ | ​ | ​ | ​       | ​ | — | ​ | ​ | ​ | ​       | ​ |       — | ​ | ​ |
| Liabilities:                            | ​ | ​ | ​                   | ​ |         ​ | ​ | ​ | ​ | ​       | ​ |         ​ | ​ | ​ | ​ | ​       | ​ | ​ | ​ | ​ | ​ | ​       | ​ |       ​ | ​ | ​ |
| Public Warrants                         | ​ | ​ | ​                   | ​ |   207,690 | ​ | ​ | ​ | ​       | ​ |   207,690 | ​ | ​ | ​ | ​       | ​ | — | ​ | ​ | ​ | ​       | ​ |       — | ​ | ​ |
| Private Warrants                        | ​ | ​ | ​                   | ​ |   168,754 | ​ | ​ | ​ | ​       | ​ |         — | ​ | ​ | ​ | ​       | ​ | — | ​ | ​ | ​ | ​       | ​ | 168,754 | ​ | ​ |
| Derivative liability                    | ​ | ​ | ​                   | $ |     2,202 | ​ | ​ | ​ | ​       | $ |         — | ​ | ​ | ​ | ​       | $ | — | ​ | ​ | ​ | ​       | $ |   2,202 | ​ | ​ |

Measurement — The Company established the initial fair value for the warrants on March 9, 2021, the date of the consummation of the IPO. On September 30, 2024 and December 31, 2023, the fair value was

F-24

TABLE OF CONTENTS

IRIS ACQUISITION CORP NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS remeasured. In May 2021,